Tag Archives: Michele Meixell

AstraZeneca will use BenevolentAI’s advanced AI to dive into its disease area expertise and massive datasets to gain insights into the complex disease biology

AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney disease and idiopathic pulmonary fibrosis CAMBRIDGE / LONDON, 30-Apr-2019 — /EuropaWire/ — New partnership, announced today, by AstraZeneca and BenevolentAI … Read the full press release

AstraZeneca: temporary injunction against the US launch of Hanmi’s 505(b)2 NDA esomeprazole strontium lifted by Court of Appeals for the Federal Circuit (CAFC)

London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that the US Court of Appeals for the Federal Circuit (CAFC) lifted a temporary injunction against the US launch of Hanmi’s 505(b)2 NDA esomeprazole strontium product. AstraZeneca’s CAFC appeal of claim construction … Read the full press release